MIRA
INFORM REPORT
|
Report Date : |
03.01.2008 |
IDENTIFICATION
DETAILS
|
Name : |
TERAPEUTICA BOLIVIANA S.A. |
|
|
|
|
Registered Office : |
Calle 2 Este No.3205 Barrio Hamacas, Santa Cruz |
|
|
|
|
Country : |
Republic of Bolivia |
|
|
|
|
Date of Incorporation : |
1980 |
|
|
|
|
Legal Form : |
Public Limited Company |
|
|
|
|
Line of Business : |
Medicinal Products For Human Use |
RATING &
COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
Registered Name
TERAPEUTICA BOLIVIANA S.A.
"TERBOL S.A."
NIT: 1028129026
Summary
INCORPORATED IN
1980. BEGINNER OF ACTIVITIES. ITS DIRECTORS REFUSED TO SUPPLY FINANCIAL INFORMATION.
IT DOESN'T REGISTER THAT COULD AFFECT ITS CONCEPT. FOR CREDIT TREATMENT, TAKE
APPROPRIATE ADDITIONAL GUARANTEES.
Operations
MEDICINAL PRODUCTS
FOR HUMAN USE
ELABORATION
COMMERCIALIZATION
Legal Structure
Business type:
Public Limited Company
Incorporated: 1980
Registered: Santa Cruz City
Duration: Unlimited
End of fiscal year: March 31st
Contact
Accountant: Lucía
Guzman.
Operative and Administrative address: Calle 2 Este No.3205 Barrio Hamacas,
Santa Cruz, Republic of Bolivia.
Phone: (591-33) 426767
Fax: (591-33) 426566
E-mail: terbol@terbol.com
Partners
President:
MORALES URQUIZA MARCELO
Mr Morales, as Manager, is in charge of the management and administration of
the company, with the use of the social signature.
History
Fits to highlight
that the Accountant Lucía Guzman refused to attend our requirement despite we
mention the company PSA INTERNATIONAL as the one who required the data.
Therefore, it has been necessary to consult other sources and our registered
information.
It is beginner of activities and operates in the previously exposed address.
It isn’t known if it is member of any economic group or of its directors
perform other activities.
Economic-Financial
Position
Due to the
mentioned reasons, it has not been possible to obtain figures or copy of the
Balance Sheet in order to determine the company's current economic-financial
position.
Therefore it has been necessary to consult other sources. And even in this way,
no information about this company was registered, although it has been
mentioned that the subject is a company of reasonable importance on its sector.
Assets
REAL ESTATE:
------------
Inside the company's fixed assets is included the property located in the
previously exposed address, which has a good realization value.
VEHICLES:
---------
It owns several vehicles (no details were obtained).
Evolution and Results
It is engaged in
the elaboration and commercialization of medicinal products for human use,
operating nowadays in the previously exposed address.
It has a large-sized building with its administrative offices, production area,
warehouses, etc., which are managed by the main directors together with the
necessary staff.
It carries out imports (80% of its purchases) from Brazil, India, Chile,
Germany, Switzerland and Argentina, making exports to Peru.
* 320 EMPLOYEES
MAIN SUPPLIERS:
---------------
FAVIMA S.A.
Avda.B.Vicuña Mackena 2481
Santiago (Chile)
WHEATON DO BRASIL IND.E COMERCIO LTDA.
Avda.Alvaro Guimaraes 2502, Vía Euro
San Pablo (Brazil)
Payment Record and Credit
Risk
BANKS:
------
BANCO BISA Branch: Santa
Cruz
BANCO DE CREDITO Branch: Santa Cruz
INSURANCE:
----------
SEGUROS ALIANZA S.A.
Concept
It is commercially
related with companies of this and other markets. Many of them give it their
credit treatment, not making up to now objections about its payment record.
* FULFILLMENT: NOT OBJECTED
Final Opinion
Bearing in mind
the fact that it has not been possible to determine the company's current
economic-financial situation, for credit treatment we suggest operating over
very firm bases.
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)